[Statistic considerations in the treatment of patients with coagulation disorders: 2 methods of approach].
D001778:Blood Coagulation Disorders / Q000503:physiopathology* / Q000628:therapy; D003730:Dental Care for Persons with Disabilities; D004338:Drug Combinations / Q000627:therapeutic use; D005169:Factor VIII / Q000627:therapeutic use; D005176:Factor XIII / Q000627:therapeutic use; D015718:Fibrin Tissue Adhesive; D005340:Fibrinogen / Q000627:therapeutic use; D006467:Hemophilia A / Q000503:physiopathology / Q000628:therapy; D006801:Humans; D013917:Thrombin / Q000627:therapeutic use; D014014:Tissue Adhesives / Q000627:therapeutic use; D014842:von Willebrand Diseases / Q000503:physiopathology / Q000628:therapy
D004338:Drug Combinations; D015718:Fibrin Tissue Adhesive; D014014:Tissue Adhesives; C026912:cryoprecipitate coagulum; D005169:Factor VIII; D005340:Fibrinogen; D005176:Factor XIII; D013917:Thrombin
Considerazioni statistiche sul trattamento dei pazienti coaulopatici: due metodi a confronto.